M. Vigolo

Discipline

Histoire, Philosophie et Sociologie des sciences (1)

Type de document

Articles (10)

Co-auteur

Date

Source

Mot-clé

Mice (7) famille (6) Families (6) Family (6) protéine (5) Treatment (5) anticorps (4) survie (4) Inhibitors (4) Survival (4) Patients (4) Human beings (4) Cells (4) Receptors (4) Patients (4) région (3) mutation (3) Tumor necrosis factor (3) Systemic lupus erythematosus (3) Ligands (3) Inhibition (3) Ectodermal dysplasia (3) Cytokines (3) B cells (3) Autoimmune diseases (3) Monoclonal antibodies (3) Animals (3) Mutation (3) administration (2) puits (2)

Documents écrit par M. Vigolo (10) | parle de M. Vigolo (0)

Ligand-independent oligomerization of TACI is controlled by the transmembrane domain and regulates proliferation of activated B cells.
C.R. Smulski et al. (29 mars 2022)
Methods for the Administration of EDAR Pathway Modulators in Mice.
S. Schuepbach-Mallepell et al. (2021)
No interactions between heparin and atacicept, an antagonist of B cell survival cytokines.
C. Kowalczyk-Quintas et al.
A loop region of BAFF controls B cell survival and regulates recognition by different inhibitors.
M. Vigolo et al. (23 mars 2018)
Inhibition of Membrane-Bound BAFF by the Anti-BAFF Antibody Belimumab.
C. Kowalczyk-Quintas et al. (2018)
Prenatal Correction of X-Linked Hypohidrotic Ectodermal Dysplasia.
H. Schneider et al. (2018)
A mouse model of systemic lupus erythematosus responds better to soluble TACI than to soluble BAFFR, correlating with depletion of plasma cells.
P. Haselmayer et al. (2017)
Ectodysplasin A in Biological Fluids and Diagnosis of Ectodermal Dysplasia.
J. Podzus et al. (2017)
Antibodies That Block or Activate Mouse B Cell Activating Factor of the Tumor Necrosis Factor (TNF) Family (BAFF), Respectively, Induce B Cell Depletion or B Cell Hyperplasia.
C. Kowalczyk-Quintas et al. (16 sept. 2016)
Stoichiometry of heteromeric BAFF and APRIL cytokines dictates their receptor binding and signaling properties.
S. Schuepbach-Mallepell et al. (2015)